Global Molecular Cytogenetics Market Size 2024, Forecast To 2033

6 Mar, 2024

The molecular cytogenetics market size has grown rapidly in recent years. It will grow from $2.65 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rise in genetic disorders and cancer cases, growing demand for personalized medicine, research and development in life sciences, clinical applications for prenatal and postnatal diagnosis, global initiatives in genomic medicine. The molecular cytogenetics market size is expected to see strong growth in the next few years. It will grow to $4.24 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emergence of next-generation sequencing (NGS), increased focus on liquid biopsies, growing application in cancer research, expanding applications in infectious disease diagnosis, rapid growth in genetic testing services. Major trends in the forecast period include next-generation sequencing (NGS) in cytogenetic, automation and high-throughput screening, fluorescence in situ hybridization (FISH) advancements, rising application in cancer diagnostics, single-cell analysis.

Global Molecular Cytogenetics Market Key Driver

The rising prevalence of genetic disorders and cancer is expected to propel the growth of the molecular cytogenetics market in the coming years. Cancer, characterized by uncontrolled cell growth and proliferation, poses a significant health challenge worldwide. Molecular cytogenetics involves the analysis of tissue and blood samples to detect chromosomal abnormalities, which can indicate genetic disorders or certain types of cancer. Consequently, the increasing incidence of genetic disorders and cancer is set to drive the demand for molecular cytogenetics solutions. As projected by the American Cancer Society, by 2040, the global burden of cancer is estimated to reach 27.5 million new cases and 16.3 million deaths. Moreover, in 2022 alone, the United States reported 1,918,030 new cancer cases and 609,360 cancer-related deaths, including an average of 350 daily deaths attributed to lung cancer. Thus, the escalating incidence of genetic disorders and cancer serves as a significant driver for the growth of the molecular cytogenetics market, mirroring its prominence in 2023.

Get A Free Sample Of The Global Molecular Cytogenetics Market Report

Global Molecular Cytogenetics Market Segments

The molecular cytogenetics market covered in this report is segmented –
1) By Product: Instruments, Kits And Reagents, Software, Services, Consumables Or Accessories
2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Immunohistochemistry, Karyotyping, Other Technologies
3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications
4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users
By Geography:The regions covered in the molecular cytogenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain North America was the largest region in the molecular cytogenetics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in the molecular cytogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Major Molecular Cytogenetics Industry Players

Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, NeoGenomics Laboratories Inc, Quest Diagnostics, F. Hoffmann-La Roche AG, Bi Biological industries, Cytognomix Inc, Empire Genomics LLC., Genial Genetic Solutions Ltd., BioChain Institute Inc., BioGenex Laboratories Inc., Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, MolecularMD Corporation, Natera Inc., Opko Health Inc., PathGroup Inc., Roche Diagnostics Corporation, SciGene Corporation, SkylineDx B.V.

Get The Full Global Molecular Cytogenetics Market Report

Molecular Cytogenetics Market Overview

Molecular cytogenetics refers to a set of techniques that operate with the entire genome or with specific targeted DNA sequences. It includes the structural and functional organization of the chromosome and nucleus, genome variation, expression, evolution, chromosome abnormalities, and genomic variations in the context of medical genetics and tumor genetics.

Molecular Cytogenetics Global Market Report 2023 provides data on the global molecular cytogenetics market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The molecular cytogenetics market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.